美国食品药品监督管理局表示，Hologic Inc.今年早些时候召回相关产品后，美国正出现乳腺活检针短缺。
据 Bloomberg 报道，这可能导致患者乳腺癌诊断延迟。
美国FDA：Hologic召回致乳腺活检针短缺
2026-06-17 17:09:40
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Next article：
Brevan Howard拟向股票对冲基金出资
